How I Cured My SIBO: My Story of Diagnosis & Recovery

Recovering from small intestinal bacterial overgrowth is possible, but it rarely follows a straight line. Most people who successfully clear SIBO describe a process that involves getting the right diagnosis, choosing an effective antimicrobial strategy, and then doing the harder work of figuring out why the overgrowth happened in the first place. That last part is what separates people who stay well from those who relapse within months. The science behind SIBO treatment has sharpened considerably in the last decade, and understanding it can save you a lot of wasted time and money.

Why SIBO Happens in the First Place

Your small intestine is not supposed to harbor large colonies of bacteria. It has built-in defenses: stomach acid kills many organisms on contact, bile has antimicrobial properties, and a rhythmic muscular wave called the migrating motor complex sweeps debris and bacteria downward between meals. When any of these defenses weaken, bacteria from the colon can migrate upward or resident bacteria can multiply unchecked.

The migrating motor complex is one of the most important of these defenses. Its most active phase has long been recognized as the “housekeeper” of the gut, and disruptions to this pattern are associated with bacterial overgrowth.¹ If you’ve had food poisoning, there’s a specific mechanism by which the infection can damage this motility long-term. Research in animal models has shown that Campylobacter jejuni infection triggers antibodies that cross-react with vinculin, a protein involved in nerve and muscle function in the gut wall. Rats that developed SIBO after infection had significantly higher levels of these cross-reactive antibodies than those that didn’t.² This autoimmune damage to gut motility is one of the most common pathways to chronic SIBO.

Another underappreciated factor is the ileocecal valve, the muscular sphincter between your small and large intestine. It acts as a one-way gate, keeping colonic bacteria from backwashing into the small bowel. Multiple studies have found that people with SIBO are far more likely to have a weak or dysfunctional ileocecal valve. One study found that low valve pressure was present in about three-quarters of patients with a positive breath test, compared to only about 14 percent of those testing negative.³ Earlier work confirmed that low valve pressure is significantly associated with SIBO.⁴ These patients also had slower small bowel transit and higher gastric pH, which means multiple defenses were compromised at once. If your practitioner only treats the bacteria without investigating what let them accumulate, you’re likely to end up back where you started.

Getting Diagnosed Without Going in Circles

The standard first-line test for SIBO is a breath test. You drink a sugar solution, usually lactulose or glucose, and then breathe into collection tubes at regular intervals. Bacteria in the small intestine ferment the sugar and produce gases that show up in your breath. A rise in hydrogen, methane, or both within a certain time window suggests overgrowth.

These tests are far from perfect. A meta-analysis of their accuracy found that the lactulose breath test had a pooled sensitivity of about 42 percent and the glucose breath test about 55 percent, with specificities of roughly 71 and 83 percent respectively.⁵ In plain terms, the glucose test is better at correctly identifying people who actually have SIBO, but neither test catches everyone. A comparison study found that the lactulose test flagged significantly more cases of bacterial overgrowth than the glucose test, suggesting each test has blind spots the other doesn’t.⁶

Duodenal aspiration, where fluid is collected directly from the small intestine during an endoscopy, is sometimes called the gold standard, but it has its own problems. One study found that culture identified overgrowth in about 45 percent of patients with suspected SIBO, and the glucose breath test agreed with the culture result only about two-thirds of the time.⁷ This means even the most invasive test misses cases, partly because the overgrowth can be patchy or located further down than where the scope reaches.

One important pitfall: people with faster gut transit can get false positives on the lactulose breath test because the sugar reaches the colon before the test window ends, and colonic bacteria produce a gas rise that gets misread as small intestinal overgrowth. A study of gastric bypass patients found that when breath test results were cross-referenced with actual transit time, about 28 percent of positive results were likely false positives.⁸ If you’ve had abdominal surgery or have known rapid transit, discuss this with your doctor before assuming a positive lactulose test is definitive.

The Three Gas Types and Why They Matter

SIBO is not one condition with one presentation. The gas your overgrown bacteria produce shapes your symptoms and determines which treatment is most likely to work.

Hydrogen-dominant SIBO tends to cause diarrhea, urgency, and cramping. Methane-dominant overgrowth, now sometimes called intestinal methanogen overgrowth (IMO), leans the other direction. Methane was once thought to be an inert byproduct, but research has established that it actively slows gut transit. It behaves as a neuromuscular signaling molecule, affecting both ileal and colonic motility, and is closely tied to constipation-predominant IBS.⁹ The primary organism responsible is an archaeon called Methanobrevibacter smithii. Patients with constipation-predominant IBS carry dramatically higher loads of M. smithii than those with diarrhea-predominant IBS or healthy controls, and the organism’s abundance inversely correlates with stool frequency.¹⁰ The quantity of M. smithii is also proportional to the amount of methane detected on a breath test.¹¹

The third gas, hydrogen sulfide, is the newest to gain clinical attention. A large real-world study using three-gas breath testing found that higher levels of breath hydrogen sulfide correlated with more severe diarrhea, more urgent bowel movements, and more abdominal pain.¹² Research on hydrogen sulfide in the breath of IBS patients has suggested it may serve as a biomarker for SIBO in cases where the standard hydrogen breath test misses the overgrowth entirely, particularly in people whose bacteria don’t produce much hydrogen.¹³ If you’ve tested negative on a hydrogen-only breath test but still have persistent diarrhea and gut symptoms, hydrogen sulfide SIBO is worth investigating with a three-gas test.

Antibiotic Treatment and What the Numbers Actually Show

Rifaximin is the most studied antibiotic for SIBO. It works primarily in the gut with minimal systemic absorption, which limits side effects. A meta-analysis of available trials found an overall eradication rate of about 71 percent, with a side-effect rate under 5 percent.¹⁴ That’s a decent success rate, but it means roughly three in ten people don’t clear the overgrowth on a standard course.

One approach that improved these odds was combining rifaximin with partially hydrolysed guar gum, a prebiotic fiber. A clinical trial found the combination achieved an eradication rate of about 85 percent, compared to 62 percent for rifaximin alone.¹⁵ The idea is that the fiber feeds the bacteria, making them more metabolically active and therefore more susceptible to the antibiotic. This may seem counterintuitive when you’re trying to kill off bacteria, but it’s a well-established principle in microbiology: dormant bacteria are harder to kill than actively dividing ones.

For methane-dominant cases, rifaximin alone often isn’t enough. The archaea that produce methane aren’t technically bacteria, and they can be resistant to antibiotics that work on conventional bacteria. Practitioners commonly add neomycin or metronidazole to the regimen for methane producers, though published trial data for these combinations specifically in SIBO is thinner than for rifaximin monotherapy.

Herbal Antimicrobials as an Alternative

If you can’t access rifaximin, can’t tolerate it, or prefer a non-pharmaceutical approach, herbal antimicrobials are a legitimate option with published evidence behind them. A study comparing herbal protocols to rifaximin found that about 46 percent of patients on herbal therapy had a negative follow-up breath test, compared to 34 percent on rifaximin. The difference wasn’t statistically significant, which led the researchers to conclude that herbal therapies are at least as effective as rifaximin for SIBO resolution.¹⁶ The herbal protocols typically include combinations of berberine-containing herbs, oregano oil, and other botanical antimicrobials, though specific formulations varied among patients in the study.

A word of caution: “herbal” does not mean “gentle” or “without side effects.” Botanical antimicrobials can cause die-off reactions, digestive upset, and interactions with other medications. They also require a longer treatment course, typically four to six weeks compared to two weeks for rifaximin. Working with a practitioner experienced in their use makes a real difference in outcomes.

The Elemental Diet Option

For stubborn cases that don’t respond to antimicrobials, the elemental diet is the most aggressive non-surgical intervention. It consists of pre-digested nutrients (amino acids, simple sugars, and fats) that are absorbed in the very upper part of the small intestine, starving bacteria further down. A study of IBS patients with abnormal breath tests found that a 14-day elemental diet normalized the breath test in 80 percent of cases, rising to 85 percent when some patients extended to 21 days.¹⁷

Those are impressive numbers, but the elemental diet is genuinely difficult to sustain. The formulas taste medicinal, you eat no solid food for two to three weeks, and the caloric intake can be hard to maintain. Most people who’ve done it describe the first few days as the hardest, with fatigue and cravings that ease as the gut quiets down. It’s usually reserved for cases that have failed one or two rounds of antimicrobials, not used as a first-line treatment.

The Low-FODMAP Trap

Many people with SIBO land on a low-FODMAP diet because it reduces symptoms quickly. By cutting out the fermentable carbohydrates that feed gut bacteria, you feel less bloated, less gassy, and more comfortable. The problem is that this approach can backfire over time. A narrative review of dietary approaches for SIBO noted that a low-FODMAP diet may promote unfavorable shifts in the gut microbiome and could deepen the existing dysbiosis in SIBO patients.¹⁸

There’s also a psychological dimension. A study of young women found that nearly half of those following a low-FODMAP diet showed symptoms of orthorexia, a pattern of obsessive “healthy” eating that can become clinically problematic.¹⁹ A position paper from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition also cautioned that restrictive diets can affect nutritional adequacy and promote disordered eating in vulnerable individuals.²⁰ The takeaway: use low-FODMAP as a short-term symptom management tool during active treatment, not as a permanent lifestyle. The goal is to expand your diet back out as the overgrowth resolves, not to keep restricting indefinitely.

Nutritional Fallout You Might Not Expect

SIBO doesn’t just cause digestive symptoms. The excess bacteria compete with you for nutrients, and one of the most common casualties is vitamin B12. Anaerobic bacteria in the small intestine consume B12 and also interfere with its absorption. Research has noted that B12 deficiency appears commonly in SIBO patients, and that the resulting rise in homocysteine levels could theoretically increase cardiovascular risk over time.²¹ Fat-soluble vitamin deficiencies (A, D, E, K) can also develop if the overgrowth damages the intestinal lining enough to impair fat absorption. If you’ve had SIBO for months or longer, getting a comprehensive nutrient panel is worth the blood draw.

The Vagus Nerve Connection

One of the more interesting findings in SIBO research involves the vagus nerve, the long cranial nerve that connects your brain to your gut and controls much of your digestive function. A study of HIV-positive adults found that those with vagal dysfunction were more than twice as likely to have SIBO compared to those with intact vagal function. The severity of the overgrowth was also markedly worse in the vagal dysfunction group, with breath gas levels more than four times higher.²² The association was specific to vagal function rather than autonomic dysfunction generally.

This matters because vagal tone is something you can influence. Chronic stress, poor sleep, and sedentary habits all suppress vagal activity. Practices that stimulate the vagus nerve, such as cold exposure, deep slow breathing, gargling, and regular aerobic exercise, may help restore the gut motility patterns that keep bacteria in check. The evidence for these interventions specifically preventing SIBO recurrence is still emerging, but the physiological logic is sound and the interventions carry essentially no risk.

When SIBO Isn’t the Only Overgrowth

If you’ve treated SIBO and still feel off, fungal overgrowth in the small intestine is worth considering. Two studies found that roughly a quarter of patients with unexplained gastrointestinal symptoms had small intestinal fungal overgrowth, with symptoms including bloating, belching, nausea, and diarrhea.²³ The two conditions can coexist. Research comparing patients who’d had a colectomy to controls found that mixed SIBO and fungal overgrowth was three times as common in the surgical group.²⁴ Standard SIBO breath tests don’t detect fungal overgrowth, so it can persist silently after antibiotics have cleared the bacterial component. Antifungal treatment is different from antibacterial treatment, and pursuing both simultaneously or sequentially may be necessary in refractory cases.

What Actual Recovery Looks Like

Recovery from SIBO is typically iterative rather than linear. A common trajectory looks something like this: you get diagnosed, do a round of antimicrobials, feel better for a few weeks to a few months, and then symptoms creep back. The second round usually involves addressing an underlying cause, whether that’s a prokinetic agent to support the migrating motor complex, a protocol to improve vagal tone, or investigation into structural issues like a poorly functioning ileocecal valve. Each round tends to produce longer periods of remission as more root causes get addressed.

The people who do best in the long term are usually those who resist the urge to treat SIBO as purely a gut problem. If your motility is impaired because of post-infectious autoimmunity, that requires different management than SIBO caused by chronic opioid use slowing your gut, adhesions from surgery, or low stomach acid from long-term proton pump inhibitor use. The antimicrobial phase is the easy part. The detective work that follows is where lasting recovery actually happens.